secwatch.observer — SEC 8-K summary
======================================

Issuer:     C4 Therapeutics, Inc. (CCCC)
CIK:        0001662579
Form:       8-K
Filed at:   2026-04-10T23:59:59+00:00
Accession:  0001628280-26-024583
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

C4 Therapeutics amends bylaws to designate exclusive forum for federal securities claims
--------------------------------------------------------------------------------

- Board approved by-laws amendment effective April 9, 2026 designating U.S. District Courts for Massachusetts and Delaware as exclusive forums for Securities Act and Exchange Act claims.
- Amendment responds to recent changes in Delaware General Corporation Law regarding forum selection provisions.
- Company may consent in writing to an alternative forum; full text filed as Exhibit 3.1.
- No financial impact; governance change only.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662579/000162828026024583/0001628280-26-024583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662579/000162828026024583/cccc-20260410.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-024583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer